Efficient CRISPR/Cas9 Knock-in Approaches for Manipulation of Endogenous Genes in Human B Lymphoma Cells

Laura A Murray-Nerger1,2,3,4, Benjamin E Gewurz1,2,3,4

  • 1Division of Infectious Diseases, Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

Current Protocols
|November 13, 2024
PubMed